iShares Biotechnology ETF (IBB)
NASDAQ: IBB · Real-Time Price · USD
121.91
-0.94 (-0.77%)
At close: May 28, 2025, 4:00 PM
123.23
+1.32 (1.08%)
After-hours: May 28, 2025, 7:15 PM EDT
IBB Holdings List
As of May 27, 2025
No. | Symbol | Name | % Weight |
---|---|---|---|
1 | GILD | Gilead Sciences, Inc. | 8.61% |
2 | VRTX | Vertex Pharmaceuticals Incorporated | 8.39% |
3 | AMGN | Amgen Inc. | 8.19% |
4 | REGN | Regeneron Pharmaceuticals, Inc. | 7.47% |
5 | ALNY | Alnylam Pharmaceuticals, Inc. | 4.22% |
6 | IQV | IQVIA Holdings Inc. | 2.88% |
7 | ARGX | argenx SE | 2.87% |
8 | MTD | Mettler-Toledo International Inc. | 2.81% |
9 | WAT | Waters Corporation | 2.49% |
10 | NTRA | Natera, Inc. | 2.36% |
11 | BIIB | Biogen Inc. | 2.19% |
12 | BNTX | BioNTech SE | 1.89% |
13 | UTHR | United Therapeutics Corporation | 1.63% |
14 | ONC | BeiGene, Ltd. | 1.54% |
15 | ILMN | Illumina, Inc. | 1.53% |
16 | INCY | Incyte Corporation | 1.46% |
17 | INSM | Insmed Incorporated | 1.41% |
18 | NBIX | Neurocrine Biosciences, Inc. | 1.39% |
19 | EXEL | Exelixis, Inc. | 1.38% |
20 | BMRN | BioMarin Pharmaceutical Inc. | 1.28% |
21 | GMAB | Genmab A/S | 1.15% |
22 | MRNA | Moderna, Inc. | 1.07% |
23 | TECH | Bio-Techne Corporation | 0.89% |
24 | MEDP | Medpace Holdings, Inc. | 0.88% |
25 | CRL | Charles River Laboratories International, Inc. | 0.82% |
26 | HALO | Halozyme Therapeutics, Inc. | 0.78% |
27 | ASND | Ascendis Pharma A/S | 0.78% |
28 | RGEN | Repligen Corporation | 0.76% |
29 | BPMC | Blueprint Medicines Corporation | 0.74% |
30 | RVMD | Revolution Medicines, Inc. | 0.70% |
31 | IONS | Ionis Pharmaceuticals, Inc. | 0.61% |
32 | TEM | Tempus AI, Inc. | 0.60% |
33 | MDGL | Madrigal Pharmaceuticals, Inc. | 0.59% |
34 | BBIO | BridgeBio Pharma, Inc. | 0.58% |
35 | ROIV | Roivant Sciences Ltd. | 0.56% |
36 | ALKS | Alkermes plc | 0.56% |
37 | ADMA | ADMA Biologics, Inc. | 0.53% |
38 | AXSM | Axsome Therapeutics, Inc. | 0.49% |
39 | PCVX | Vaxcyte, Inc. | 0.47% |
40 | VRNA | Verona Pharma plc | 0.45% |
41 | BRKR | Bruker Corporation | 0.45% |
42 | PTCT | PTC Therapeutics, Inc. | 0.43% |
43 | ACAD | ACADIA Pharmaceuticals Inc. | 0.43% |
44 | LEGN | Legend Biotech Corporation | 0.43% |
45 | CYTK | Cytokinetics, Incorporated | 0.41% |
46 | SRPT | Sarepta Therapeutics, Inc. | 0.40% |
47 | RNA | Avidity Biosciences, Inc. | 0.40% |
48 | RYTM | Rhythm Pharmaceuticals, Inc. | 0.39% |
49 | SWTX | SpringWorks Therapeutics, Inc. | 0.38% |
50 | NUVL | Nuvalent, Inc. | 0.38% |
51 | MRUS | Merus N.V. | 0.37% |
52 | KRYS | Krystal Biotech, Inc. | 0.36% |
53 | CRSP | CRISPR Therapeutics AG | 0.36% |
54 | AKRO | Akero Therapeutics, Inc. | 0.36% |
55 | RARE | Ultragenyx Pharmaceutical Inc. | 0.36% |
56 | SMMT | Summit Therapeutics Inc. | 0.35% |
57 | PTGX | Protagonist Therapeutics, Inc. | 0.31% |
58 | CRNX | Crinetics Pharmaceuticals, Inc. | 0.30% |
59 | ACLX | Arcellx, Inc. | 0.29% |
60 | ZLAB | Zai Lab Limited | 0.28% |
61 | SRRK | Scholar Rock Holding Corporation | 0.26% |
62 | XENE | Xenon Pharmaceuticals Inc. | 0.26% |
63 | VCYT | Veracyte, Inc. | 0.25% |
64 | BCRX | BioCryst Pharmaceuticals, Inc. | 0.25% |
65 | VCEL | Vericel Corporation | 0.24% |
66 | NVCR | NovoCure Limited | 0.22% |
67 | FOLD | Amicus Therapeutics, Inc. | 0.22% |
68 | APLS | Apellis Pharmaceuticals, Inc. | 0.21% |
69 | MIRM | Mirum Pharmaceuticals, Inc. | 0.20% |
70 | AGIO | Agios Pharmaceuticals, Inc. | 0.20% |
71 | DNLI | Denali Therapeutics Inc. | 0.19% |
72 | TWST | Twist Bioscience Corporation | 0.19% |
73 | ARWR | Arrowhead Pharmaceuticals, Inc. | 0.19% |
74 | GRFS | Grifols, S.A. | 0.19% |
75 | IDYA | IDEAYA Biosciences, Inc. | 0.18% |
76 | KYMR | Kymera Therapeutics, Inc. | 0.18% |
77 | BEAM | Beam Therapeutics Inc. | 0.18% |
78 | ARQT | Arcutis Biotherapeutics, Inc. | 0.17% |
79 | TARS | Tarsus Pharmaceuticals, Inc. | 0.16% |
80 | BHVN | Biohaven Ltd. | 0.16% |
81 | TVTX | Travere Therapeutics, Inc. | 0.16% |
82 | APGE | Apogee Therapeutics, Inc. | 0.16% |
83 | ADPT | Adaptive Biotechnologies Corporation | 0.15% |
84 | RXRX | Recursion Pharmaceuticals, Inc. | 0.15% |
85 | ETNB | 89bio, Inc. | 0.15% |
86 | MNKD | MannKind Corporation | 0.15% |
87 | ALVO | Alvotech | 0.15% |
88 | GRAL | GRAIL, Inc. | 0.14% |
89 | CGON | CG Oncology, Inc. | 0.14% |
90 | JANX | Janux Therapeutics, Inc. | 0.14% |
91 | DVAX | Dynavax Technologies Corporation | 0.14% |
92 | STVN | Stevanato Group S.p.A. | 0.13% |
93 | NVAX | Novavax, Inc. | 0.13% |
94 | EWTX | Edgewise Therapeutics, Inc. | 0.12% |
95 | AUPH | Aurinia Pharmaceuticals Inc. | 0.12% |
96 | EVO | Evotec SE | 0.12% |
97 | IMVT | Immunovant, Inc. | 0.12% |
98 | IMCR | Immunocore Holdings plc | 0.12% |
99 | DYN | Dyne Therapeutics, Inc. | 0.12% |
100 | IRON | Disc Medicine, Inc. | 0.11% |
101 | MESO | Mesoblast Limited | 0.11% |
102 | GLPG | Galapagos NV | 0.11% |
103 | NAMS | NewAmsterdam Pharma Company N.V. | 0.11% |
104 | VERA | Vera Therapeutics, Inc. | 0.11% |
105 | NTLA | Intellia Therapeutics, Inc. | 0.11% |
106 | GPCR | Structure Therapeutics Inc. | 0.11% |
107 | GERN | Geron Corporation | 0.10% |
108 | CDNA | CareDx, Inc | 0.10% |
109 | XTSLA | BLK CSH FND TREASURY SL AGENCY | 0.10% |
110 | TXG | 10x Genomics, Inc. | 0.10% |
111 | SNDX | Syndax Pharmaceuticals, Inc. | 0.10% |
112 | SYRE | Spyre Therapeutics, Inc. | 0.09% |
113 | CRMD | CorMedix Inc. | 0.09% |
114 | SPRY | ARS Pharmaceuticals, Inc. | 0.09% |
115 | ZYME | Zymeworks Inc. | 0.09% |
116 | QURE | uniQure N.V. | 0.09% |
117 | NRIX | Nurix Therapeutics, Inc. | 0.09% |
118 | WVE | Wave Life Sciences Ltd. | 0.09% |
119 | CNTA | Centessa Pharmaceuticals plc | 0.08% |
120 | LENZ | LENZ Therapeutics, Inc. | 0.08% |
121 | PRAX | Praxis Precision Medicines, Inc. | 0.07% |
122 | AVXL | Anavex Life Sciences Corp. | 0.07% |
123 | MLYS | Mineralys Therapeutics, Inc. | 0.07% |
124 | ANAB | AnaptysBio, Inc. | 0.07% |
125 | USD | USD CASH | 0.07% |
126 | RCUS | Arcus Biosciences, Inc. | 0.06% |
127 | REPL | Replimune Group, Inc. | 0.06% |
128 | XNCR | Xencor, Inc. | 0.06% |
129 | NUVB | Nuvation Bio Inc. | 0.06% |
130 | ABUS | Arbutus Biopharma Corporation | 0.06% |
131 | ELVN | Enliven Therapeutics, Inc. | 0.06% |
132 | KROS | Keros Therapeutics, Inc. | 0.06% |
133 | DAWN | Day One Biopharmaceuticals, Inc. | 0.05% |
134 | COGT | Cogent Biosciences, Inc. | 0.05% |
135 | IOVA | Iovance Biotherapeutics, Inc. | 0.05% |
136 | ZVRA | Zevra Therapeutics, Inc. | 0.05% |
137 | ABCL | AbCellera Biologics Inc. | 0.05% |
138 | CSTL | Castle Biosciences, Inc. | 0.05% |
139 | KALV | KalVista Pharmaceuticals, Inc. | 0.05% |
140 | ALT | Altimmune, Inc. | 0.05% |
141 | TBPH | Theravance Biopharma, Inc. | 0.05% |
142 | ETR: 5CV | CureVac N.V. | 0.05% |
143 | RGNX | REGENXBIO Inc. | 0.05% |
144 | VIR | Vir Biotechnology, Inc. | 0.05% |
145 | KURA | Kura Oncology, Inc. | 0.05% |
146 | OPK | OPKO Health, Inc. | 0.05% |
147 | TSHA | Taysha Gene Therapies, Inc. | 0.05% |
148 | ARVN | Arvinas, Inc. | 0.05% |
149 | AVBP | ArriVent BioPharma, Inc. | 0.05% |
150 | FLGT | Fulgent Genetics, Inc. | 0.05% |
151 | STOK | Stoke Therapeutics, Inc. | 0.04% |
152 | LAB | Standard BioTools Inc. | 0.04% |
153 | FTRE | Fortrea Holdings Inc. | 0.04% |
154 | RLAY | Relay Therapeutics, Inc. | 0.04% |
155 | MYGN | Myriad Genetics, Inc. | 0.04% |
156 | SAGE | Sage Therapeutics, Inc. | 0.04% |
157 | RIGL | Rigel Pharmaceuticals, Inc. | 0.04% |
158 | EBS | Emergent BioSolutions Inc. | 0.04% |
159 | ORKA | Oruka Therapeutics, Inc. | 0.04% |
160 | TRVI | Trevi Therapeutics, Inc. | 0.04% |
161 | HUMA | Humacyte, Inc. | 0.04% |
162 | CTKB | Cytek Biosciences, Inc. | 0.04% |
163 | AMLX | Amylyx Pharmaceuticals, Inc. | 0.03% |
164 | ARCT | Arcturus Therapeutics Holdings Inc. | 0.03% |
165 | ABSI | Absci Corporation | 0.03% |
166 | TYRA | Tyra Biosciences, Inc. | 0.03% |
167 | VERV | Verve Therapeutics, Inc. | 0.03% |
168 | OLMA | Olema Pharmaceuticals, Inc. | 0.03% |
169 | CGEM | Cullinan Therapeutics, Inc. | 0.03% |
170 | AURA | Aura Biosciences, Inc. | 0.03% |
171 | MGTX | MeiraGTx Holdings plc | 0.03% |
172 | AUTL | Autolus Therapeutics plc | 0.03% |
173 | ITOS | iTeos Therapeutics, Inc. | 0.03% |
174 | ALMS | Alumis Inc. | 0.03% |
175 | CMPS | COMPASS Pathways plc | 0.03% |
176 | MRVI | Maravai LifeSciences Holdings, Inc. | 0.03% |
177 | DNA | Ginkgo Bioworks Holdings, Inc. | 0.03% |
178 | SANA | Sana Biotechnology, Inc. | 0.03% |
179 | TRML | Tourmaline Bio, Inc. | 0.03% |
180 | ORIC | ORIC Pharmaceuticals, Inc. | 0.03% |
181 | VNDA | Vanda Pharmaceuticals Inc. | 0.03% |
182 | BCYC | Bicycle Therapeutics plc | 0.03% |
183 | RCKT | Rocket Pharmaceuticals, Inc. | 0.03% |
184 | MXCT | MaxCyte, Inc. | 0.03% |
185 | TECX | Tectonic Therapeutic, Inc. | 0.03% |
186 | PGEN | Precigen, Inc. | 0.03% |
187 | IBRX | ImmunityBio, Inc. | 0.03% |
188 | PACB | Pacific Biosciences of California, Inc. | 0.03% |
189 | AVIR | Atea Pharmaceuticals, Inc. | 0.03% |
190 | SLDB | Solid Biosciences Inc. | 0.02% |
191 | PSNL | Personalis, Inc. | 0.02% |
192 | CDXS | Codexis, Inc. | 0.02% |
193 | NGNE | Neurogene Inc. | 0.02% |
194 | IMMP | Immutep Limited | 0.02% |
195 | PRTA | Prothena Corporation plc | 0.02% |
196 | TERN | Terns Pharmaceuticals, Inc. | 0.02% |
197 | ATXS | Astria Therapeutics, Inc. | 0.02% |
198 | ADCT | ADC Therapeutics SA | 0.02% |
199 | GLUE | Monte Rosa Therapeutics, Inc. | 0.02% |
200 | ANNX | Annexon, Inc. | 0.02% |
201 | ERAS | Erasca, Inc. | 0.02% |
202 | SVRA | Savara Inc. | 0.02% |
203 | RAPP | Rapport Therapeutics, Inc. | 0.02% |
204 | CRVS | Corvus Pharmaceuticals, Inc. | 0.02% |
205 | TRDA | Entrada Therapeutics, Inc. | 0.02% |
206 | QTRX | Quanterix Corporation | 0.02% |
207 | CYBN | Cybin Inc. | 0.02% |
208 | INZY | Inozyme Pharma, Inc. | 0.02% |
209 | PHAT | Phathom Pharmaceuticals, Inc. | 0.02% |
210 | YMAB | Y-mAbs Therapeutics, Inc. | 0.02% |
211 | ALLO | Allogene Therapeutics, Inc. | 0.02% |
212 | EDIT | Editas Medicine, Inc. | 0.02% |
213 | URGN | UroGen Pharma Ltd. | 0.02% |
214 | SLN | Silence Therapeutics plc | 0.02% |
215 | FDMT | 4D Molecular Therapeutics, Inc. | 0.02% |
216 | INBX | Inhibrx Biosciences, Inc. | 0.02% |
217 | FATE | Fate Therapeutics, Inc. | 0.01% |
218 | VYGR | Voyager Therapeutics, Inc. | 0.01% |
219 | CRGX | CARGO Therapeutics, Inc. | 0.01% |
220 | DSGN | Design Therapeutics, Inc. | 0.01% |
221 | TNGX | Tango Therapeutics, Inc. | 0.01% |
222 | CATX | Perspective Therapeutics, Inc. | 0.01% |
223 | SGAFT | CASH COLLATERAL USD SGAFT | 0.01% |
224 | ENTA | Enanta Pharmaceuticals, Inc. | 0.01% |
225 | FHTX | Foghorn Therapeutics Inc. | 0.01% |
226 | THRD | Third Harmonic Bio, Inc. | 0.01% |
227 | ACIU | AC Immune SA | 0.01% |
228 | ALEC | Alector, Inc. | 0.01% |
229 | IRWD | Ironwood Pharmaceuticals, Inc. | 0.01% |
230 | MGNX | MacroGenics, Inc. | 0.01% |
231 | NKTX | Nkarta, Inc. | 0.01% |
232 | RNAC | Cartesian Therapeutics, Inc. | 0.01% |
233 | CCCC | C4 Therapeutics, Inc. | 0.01% |
234 | PLRX | Pliant Therapeutics, Inc. | 0.01% |
235 | LRMR | Larimar Therapeutics, Inc. | 0.01% |
236 | PRME | Prime Medicine, Inc. | 0.01% |
237 | LXEO | Lexeo Therapeutics, Inc. | 0.01% |
238 | TKNO | Alpha Teknova, Inc. | 0.01% |
239 | STRO | Sutro Biopharma, Inc. | 0.01% |
240 | CLYM | Climb Bio, Inc. | 0.01% |
241 | PYXS | Pyxis Oncology, Inc. | 0.01% |
242 | TCRX | TScan Therapeutics, Inc. | 0.01% |
243 | KYTX | Kyverna Therapeutics, Inc. | 0.01% |
244 | LYEL | Lyell Immunopharma, Inc. | 0.01% |
245 | BMEA | Biomea Fusion, Inc. | 0.01% |
246 | PEPG | PepGen Inc. | 0.01% |
247 | NMRA | Neumora Therapeutics, Inc. | 0.00% |
248 | APLT | Applied Therapeutics, Inc. | 0.00% |
249 | TVGN | Tevogen Bio Holdings Inc. | 0.00% |
250 | MRSN | Mersana Therapeutics, Inc. | 0.00% |
251 | ACRV | Acrivon Therapeutics, Inc. | 0.00% |
252 | ARTV | Artiva Biotherapeutics, Inc. | 0.00% |
253 | OKUR | OnKure Therapeutics, Inc. | 0.00% |
254 | IGMS | IGM Biosciences, Inc. | 0.00% |
255 | ADRO | CHINOOK THERAPEUTICS INC | 0.00% |
256 | QTTB | Q32 Bio Inc. | 0.00% |
257 | - | CARTESIAN THERAPEUTICS INC | 0.00% |
258 | - | FUSION PHARMACEUTICALS INC CVR | 0.00% |
259 | - | AKOUOS CVRS Prvt | 0.00% |
260 | - | OMNIAB INC $15.00 VESTING Prvt | 0.00% |
261 | - | OMNIAB INC $12.50 VESTING Prvt | 0.00% |
262 | RTYM5 | RUSSELL 2000 EMINI CME JUN 25 | 0.00% |
263 | IXCM5 | E-MINI HEALTH CARE SECTOR JUN 25 | 0.00% |
As of May 27, 2025